RxDoctor Payments Data

Amani Politano, MD

Vascular Surgery · Fishersville, VANPI 1326207739

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,710 of the $2,725 with a category attached, or 62.8%. W. L. Gore & Associates, Inc. accounts for 75.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $2,000 and has fallen 88.6% since, to $228 in 2025. That places this record below the midpoint for vascular surgery clinicians in VA, where the typical reported total is $4,916.

$2,725in general payments, 2019–2025

Across 18 payments — averaging $151.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$2K
  • Medtronic$284
  • Inari Medical, Inc.$162
  • Boston Scientific$147
  • Shockwave Medical, Inc$51
  • Lemaitre Vascular, Inc.$14
$24,109in research payments, 2019–2025

Across 3 payments — averaging $8036.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bolton Medical Inc$24K

What the payments were for

  • Travel & lodging$1,71063%
  • Food & beverage$1,01537%

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,725 in reported general payments places this provider in the 30th percentile of 143 vascular surgery providers in Virginia.

See all vascular surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$58,363
Medicare patients
477
Services billed
721

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban16$10,546
ClopidogrelClopidogrel Bisulfate15$102

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Fishersville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →